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Background—Fibrous cap thickness (FCT) is an important determinant of atheroma stability. We evaluated the feasibility
and potential clinical implications of measuring the FCT of internal carotid artery plaques with a new ultrasound system
based on boundary detection by dynamic programming.
Methods and Results—We assessed agreement between ultrasound-obtained FCT values and those measured histologi-
cally in 20 patients (symptomatic [S]9, asymptomatic [AS]11) who underwent carotid endarterectomy for stenosing
(70%) carotid atheromas. We subsequently measured in vivo the FCT of 58 stenosing internal carotid artery plaques
(S22, AS36) in 54 patients. The accuracy in discriminating symptomatic from asymptomatic plaques was assessed
by receiver operating characteristic curves for the minimal, mean, and maximal FCT. Decision FCT thresholds that
provided the best correct classification rates were identified. Agreement between ultrasound and histology was
excellent, and interobserver variability was small. Ultrasound showed that symptomatic atheromas had thinner fibrous
caps (S versus AS, median [95% CI]: minimal FCT0.42 [0.34 to 0.48] versus 0.50 [0.44 to 0.53] mm, P0.024; mean
FCT0.58 [0.52 to 0.63] versus 0.79 [0.69 to 0.85] mm, P0.0001; maximal FCT0.73 [0.66 to 0.92] versus 1.04
[0.94 to 1.20] mm, P0.0001). Mean FCT measurement demonstrated the best discriminatory accuracy (area under the
curve [95% CI]: minimal 0.74 [0.61 to 0.87]; mean 0.88 [0.79 to 0.97]; maximal 0.82 [0.71 to 0.93]). The decision
threshold of 0.65 mm (mean FTC) demonstrated the best correct classification rate (82.8%; positive predictive value
75%, negative predictive value 88.2%).
Conclusions—FCT measurement of carotid atheroma with ultrasound is feasible. Discrimination of symptomatic from
asymptomatic plaques with mean FCT values is good. Prospective studies should determine whether this ultrasound
marker is reliable. (Circulation. 2005;111:2776-2782.)
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Until recently, atherosclerosis was considered a progres-sive disease that ultimately led to “hydraulic” failure.
We now have sufficient evidence to consider atherosclerosis
a chronic inflammatory disease that leads to an acute clinical
event through plaque rupture and thrombosis, rather than an
inevitable degenerative process as a consequence of aging. A
new concept, which first emerged in acute coronary syn-
dromes, is that of the “unstable” or “vulnerable” atheroscle-
rotic plaque.1 The frequency of unstable atheroma may be
underestimated and their presentation is variable, ranging
from erosion to fissure and rupture with focal defects of large
areas. Nowadays, cardiologists attribute acute coronary syn-
dromes to rupture of lipid-laden atheroma with thin fibrous
caps (FCs), because most of these plaques are not hemody-
namically significant before rupture.1
The concept of atheroma instability is currently applied in
neurology to explain artery-to-artery embolism that originates
from the internal carotid artery (ICA).2 On histological
examination,3 occluding thrombi have been found in the
carotid arteries in the absence of plaques that cause flow-
limiting stenosis. In patients dying after acute ischemic
stroke, the presence of thrombus in the ICAs is associated
with carotid plaque rupture, a thin FC, and inflammation.4–6
In other series,7,8 patients with symptomatic ICA stenosis had
a higher frequency of plaque rupture, FC thinning, and FC
foam-cell infiltration compared with the asymptomatic group.
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Up to now, in vivo diagnosis of FC thinning in symptomatic
patients with ICA stenosis was not possible. Such an ap-
proach requires an imaging technique that is noninvasive and
reliable, allows regular control to assess the evolution of
atherosclerotic carotid plaques, and is relatively inexpensive.
Noninvasive techniques for the assessment of arterial wall
pathology, such as CT angiography9 and MRI,10 are under
evaluation. Developments in ultrasound such as high-
resolution B-mode imaging, compounded imaging, measure-
ment of shear stress, characterization of plaque motion, and
4D color Doppler flow imaging are promising diagnostic
tools for carotid wall disease.11 We evaluated the feasibility
of measuring the FC thickness (FCT) of stenosing ICA
plaques with a new semiautomated ultrasound system and
investigated whether the obtained values could be used to
discriminate symptomatic from asymptomatic atheromata.
Methods
Study Design
We validated our method in 22 patients with ICA stenosis (9
symptomatic patients) who underwent carotid endarterectomy by
comparing FCT values obtained preoperatively by ultrasound with
those measured on the endarterectomy specimens. The neuropathol-
ogist (JAL) was blinded to clinical and ultrasound data. Two
investigators (GD, OC), blinded to each other’s results, performed
separate ultrasound measurements 24 hours before surgery on each
of the 20 patients. One week before surgery, one of the investigators
(GD) performed measurements for each patient for which FCT
values were stored but were not accessible to the examiner during or
after the examination. An experienced technologist who had never
performed FCT measurements was trained and subsequently per-
formed FCT assessment (steps 2 to 4 below) based on the cineloops
(step 1) acquired previously by the investigators from the same 20
patients.
We subsequently recruited consecutive patients with transient
ischemic attack or ischemic stroke who were admitted to our
department and in whom ultrasound examination within 12 hours
after admission showed 70% ipsilateral ICA stenosis. The control
group consisted of subjects who underwent exploration for carotid
bruits, preoperative screening for heart surgery, or screening for
cerebrovascular risk factors, in whom asymptomatic 70% ICA
stenosis was found. The degree of ICA stenosis was assessed
according to established criteria12 and was always confirmed by
magnetic resonance angiography. Patients with ICA occlusion de-
tected by both ultrasound and magnetic resonance angiography were
excluded from the study. All ultrasound investigations were per-
formed by 2 authors (GD, TK). Raw data were saved, and 3 months
after the end of the recruitment period, data were processed and FCT
was evaluated by 2 authors (GD, OC) blinded to the history of the
patient and to each other. To ensure blindness, raw data obtained by
GD were subsequently processed by OC, whereas data obtained by
TK were processed by GD. The study was approved by the review
committee of our institution, and all subjects gave informed consent.
Histology
Endarterectomy specimens were obtained after surgery and fixed in
4% buffered formalin solution. The entire stenotic region located at
the bifurcation and the proximal ICA was then decalcified to
facilitate specimen sectioning. Subsequently, 3- to 4-mm-thick
transverse segments were cut and embedded in paraffin blocks. Two
or 3 blocks were obtained for each specimen. From these blocks, a
total of 1016 (mean 51, range 31 to 88) transverse histological
sections 250 m thick were obtained and stained with hematoxylin-
eosin and elastica van Gieson. Sections within the site of tightest
arterial stenosis were digitized and used for FCT measurement
(Figure 1). A total of 247 sections from 20 patients were digitized
(mean 18, range 9 to 25). FCT measurements were performed with
a simple length-measurement computer system. Measurements were
taken at regular intervals ranging from 150 to 200 m and were
restricted to regions with clear demarcation of the FC-lipid core
interface. For each section, 3 to 10 FCT measurements were
performed (Figure 1). The number of FTC measurements fluctuated
for each section due to the complex morphology of carotid athero-
sclerotic plaques (size, shape, and demarcation of the FC-lipid core
interface differed substantially among cases). The total number of
FCT measurements per specimen ranged from 9 to 198 (mean 115).
For each section, a minimal, maximal, and mean value was obtained.
The arithmetic mean of the minimal values obtained from each
section for a given specimen was considered the minimal FCT for the
patient. The same method was applied for the maximal FCT. Finally,
the arithmetic mean of all measures for every specimen was
obtained.
Ultrasound Technology
In each patient, we performed high-resolution B-mode imaging,
color Duplex flow imaging (CDFI), and power Duplex imaging
using an ATL 5000 Advanced ultrasound instrument (Phillips
Figure 1. Method of histological measurement of FC. Top,
Specimen was embedded in 3 paraffin blocks, and transverse
sections 250 m thick were obtained from each block (vertical
dotted lines). Sections exhibiting site of tightest lumen stenosis
(shaded area) were digitized, and for each digitized section,
multiple FCT measures were performed with simple length-
measurement computer system. Three to 10 FCT measurements
were performed for each section depending mainly on size of
FC. Bottom, Digitized section corresponding to most stenotic
region (between 2 solid vertical lines). In this section, 8 mea-
surements were performed (horizontal solid lines); correspond-
ing values and mean FCT are demonstrated. White crescent in
middle of lipid core is disruption artifact (elastica Van Gieson).
CCA indicates common carotid artery; ECA, external carotid
artery.
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Medical Systems SA) equipped with a large broadband linear probe
of 5 to 12 MHz, which has an axial resolution of 300 m and a
lateral resolution of 400 m. The procedure to explore the FC was
very strict and consisted of 4 steps. In the first step, the sonographer
saved a cineloop that contained 150 to 200 frames that documented
the atherosclerotic plaque responsible for the ICA stenosis. The
cineloop was then transferred to a personal computer equipped with
software (HDI Laboratory, Phillips Medical Systems SA) capable of
analyzing each of the frames saved. In the second step, the sonog-
rapher selected the CDFI frame that best demonstrated the ICA
stenosis and the residual arterial lumen (Figure 2A). The third step
consisted of working on the same frame selected previously, but this
time in high-definition B-mode (Figure 2B), because in this mode,
we obtain far better resolution than in CDFI, and because in CDFI,
the FC is frequently obscured by the “blooming artifact.” The fourth
step consisted of a semiautomated computational procedure to
measure FCT.
Ultrasound System for the Measurement of FCT
The FC was defined as a hyperechogenic structure that on CDFI and
high-resolution B-mode imaging displayed stronger echoes than the
atheromatous carotid plaque on contact with the circulating blood
(anechogenic).11 The FC covered an area of weaker echoes that
corresponded to lipid accumulation (lipid core). We have developed
a system that finds the 2 paths within a specified area that best follow
the hypoechogenic-hyperechogenic and hyperechogenic-
hypoechogenic boundaries and then measures the distance between
them (Figure 2C). The user defines 2 points that specify the exact
horizontal location of the paths and the approximate vertical location
of the FC. Two boundaries are then detected automatically as the
optimal path between the 2 markers with respect to intensity gradient
and smoothness. The boundary facing the arterial lumen marks the
calculated transition from the hypoechogenic to the hyperechogenic
region; the boundary facing the lipid core marks the calculated
transition from the hyperechogenic to the hypoechogenic region. If
the user is not satisfied with the results, manual corrections can be
made by inserting additional restriction points to change the direction
of the paths (Figure 2D). Finally, the thickness, defined as the
structure between these 2 echogenic lines, is calculated pixel by pixel
along the restriction points, and mean, maximal, and minimal FCT
values can be obtained simultaneously. Boundary detection is per-
formed with dynamic programming.13,14 This is a method that
efficiently tries all paths between 2 points and selects the optimal
one, ie, the path that optimizes a specified criterion. In our case, this
criterion was a weighted sum of several terms. The first one rewards
a vertically high-intensity gradient; this term is then weighted
according to the method published by Liang et al.13 The second term
favors a smooth curve: if 2 horizontally adjacent points on the path
have a large vertical separation, these points will be penalized by
giving the cost term a higher value. The last 2 terms constrain the
path to remain close to the manually marked restriction points. A
point on the path lying horizontally close to but vertically far from a
restriction point will be penalized. There are 2 terms for the
restriction points because the vertical influence of the 2 extreme
restriction points that define the length of the path is smaller than that
of potential additional points set to guide the internal direction of the
path.
Statistical Analyses
Agreement between ultrasound and histology for FCT values,
interobserver agreement, and repeatability of the method were
assessed by Bland-Altman analysis. Fisher exact test for dichoto-
mous variables and 2-sample t test for continuous variables were
used for the comparison of baseline characteristics between subjects
with symptomatic and asymptomatic plaques. The Mann-Whitney
test was used for comparison of FCT between the 2 groups. The
accuracy of the method in discriminating symptomatic from asymp-
tomatic plaques was assessed by receiver operating characteristic
curves for the minimal, mean, and maximal FCT measurement.
Bootstrap CIs were calculated for the cutoff points (decision FCT
thresholds) that provided the best correct classification rates.
Results
The endarterectomy specimen of 1 patient unfortunately had
undergone extensive surgical manipulation and was not
judged appropriate by the pathologist for reliable assessment
of the FC. In another patient, FC measurement was not
possible because of intense calcifications with acoustic shad-
owing. Agreement between histology and ultrasound was
excellent for the mean and maximal FCT and fair for the
Figure 2. Steps of FCT measurement. A, Sonographer identifies
CDFI frame that best depicts plaque with residual arterial lumen.
B, Color is removed. On this high-resolution B-mode frame,
concentric plaque with its FC can be identified on near (upper
white frame) and far (lower white frame) arterial wall. C, Magnifi-
cation of upper white frame (near wall). User defines 2 markers
(red squares) that specify exact horizontal location of paths and
approximate vertical location of FC. Blue line is interpolation
between adjacent markers. Two boundaries are detected auto-
matically: red line marks calculated transition from arterial lumen
to FC, green line marks calculated transition from FC to lipid
core. D, Magnification of lower white frame (far wall). Same pro-
cedure is repeated, but now green line is facing arterial lumen
and red line is facing lipid core. Two additional restriction points
were inserted manually to change direction of paths.
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minimal FCT; interobserver (GD versus OC) and intraob-
server (GD) agreement for the method was very good (Table
1; Figure 3). Interobserver agreement between the technolo-
gist and GD and intraobserver agreement for the technologist
was good (Table 1).
We studied 62 ICA plaques (S23, AS39) in 58 con-
secutive patients. After data processing, FCT evaluation was
not possible in 4 patients (S1, AS3) due to technical
problems related to the morphology of the plaque ie, intense
calcifications with acoustic shadows (2 cases) or FC too thin
to measure (2 cases). Manual corrections with insertion of
one to three additional restriction points were judged neces-
sary in 32% of the cases. The baseline characteristics of the
symptomatic and asymptomatic patients did not differ (Table
2). Twenty patients had an ischemic stroke, 1 had a hemi-
spheric transient ischemic attack, and another had amaurosis
fugax.
The obtained values of the minimal, mean, and maximal
FCT for symptomatic and asymptomatic atheroma are de-
picted in Figure 4. Symptomatic plaques had thinner FCs for
TABLE 1. Agreement Between Ultrasound and Histology and Between Different Observers
Agreement, Mean Difference % (Limits of Agreement) (n20)
Minimal FCT Mean FCT Maximal FCT
Histology vs ultrasound 3.4% (15.3% to 8.1%) 1.4% (5.8% to 3.1%) 1% (3.2% to 1.3%)
Interobserver (author GD vs author OC) 2.6% (8% to 3.6%) 2.1% (7.5% to 3.5%) 1.8% (7.1% to 4.3%)
Intraobserver (author GD) 0.8% (6% to 5.1%); 0.7% (4.6% to 4.3%); 0.9% (4.1% to 2.9%);
repeatability21 m repeatability22 m repeatability25 m
Interobserver (author GD vs technologist) 4.8% (8.8% to 5.3%) 3.6% (8.4% to 4.9%) 2.7% (7.9% to 4.8%)
Intraobserver (technologist) 1.5% (6.1% to 5.3%); 1.6% (6.6% to 5.3%); 1.1% (5.1% to 4.1%);
repeatability29 m repeatability25 m repeatability23 m
Figure 3. A-C, Bland-Altman graphs with limits of agreement between FCT values (in mm) measured by histology (H) and those
obtained from ultrasound (U). For each 20 patients, difference between FCT values obtained by the 2 methods (HU) is plotted against
their average [(HU)/2]. Graphs for mean (A), minimal (B), and maximal (C) FCT are depicted. D-I, Limits of interobserver (D-F) and
intraobserver (G-I) agreement for FCT measurement by ultrasound (n20). min indicates minimal; max, maximal.
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all kinds of measurements. As depicted by the receiver
operating characteristic curves (Figure 5), our method obtains
a fair discrimination of symptomatic from asymptomatic
plaques when measurement of the minimal FCT is performed
(median area under the curve [95% CI] 0.74 [0.61 to 0.87])
and a good discrimination for maximal (0.82 [0.71 to 0.93])
and mean (0.88 [0.79 to 0.97]) FCT measurement. The FTC
cutoff points that provided the best correct classification rate
of symptomatic plaques were 0.647 mm for mean FCT,
0.924 mm for maximal FCT, and 0.458 mm for minimal FCT
(Table 3). The number of pixels that were analyzed to
calculate FCT was higher in asymptomatic than in symptom-
atic plaques (5511.2 versus 9015.1; P0.003, Mann-
Whitney test).
Discussion
There is growing evidence that the concept of “unstable”
plaques is also applicable to carotid atheroma. The relative
rarity of borderzone infarcts and the observation of emboli in
the retina of patients with amaurosis fugax suggest that
plaque rupture may play an important role in brain embo-
lism.15 Considerable attempts have been made to predict the
occurrence of stroke by classifying carotid plaques according
to their composition. Whether differences in plaque echoge-
nicity or surface morphology can predict the clinical expres-
sion of atheroma is still debated.11 Recent studies have shown
that high-resolution MRI can visualize FCT and rupture in
vivo.10 However, the availability of this technique is currently
very limited, and the data obtained are qualitative and not
quantitative.10 The present study shows that with the devel-
opment of a semiautomated system to treat B-mode imaging,
we can accurately measure the FCT of carotid plaques. The
only 2 manual steps in the procedure are the selection of the
CDFI frame to which automated FCT measurement will be
applied and the selection of 2 points that specify the location
of the paths plus additional restriction points in a third of the
cases. This is not difficult for an experienced sonographer,
although we must always bear in mind that ultrasound
examination is observer dependent. The best compromise
must take into consideration both the central and lateral parts
of the FC. Caution must also be exercised when one deals
with concentric stenoses, because the atheroma with its FC is
often visible on both the near and far arterial walls (Figure
2B).
The results of the present study suggest an encouraging
correlation between FCT and the clinical expression of
carotid atheroma. Symptomatic plaques had much thinner
FCs than asymptomatic ones, and this held true regardless of
the type of FCT measured (minimal, mean, or maximal).
Mean FCT measurement discriminates symptomatic from
asymptomatic atheroma well, although not perfectly, with a
cutoff value of 0.65 mm attaining the best correct classifica-
tion rate. The reason that minimal FCT performs the worst in
terms of discrimination is that measured values are quite
close to the axial resolution of the ultrasound instrument. This
was also reflected in the inferior (yet sufficient) degree of
agreement between histology and ultrasound for minimal
FCT values compared with maximal and mean values.
Attempts to explore the surface of atheromatous carotid
plaques with B-mode ultrasonography have already been
Figure 4. Graph depicting median with quartiles of measured
values for minimal (min), mean, and maximal (max) FC thickness
in symptomatic (S) and asymptomatic (A) internal carotid
plaques. Mann-Whitney probability values are illustrated.
TABLE 2. Baseline Variables of Patients With Symptomatic
and Asymptomatic ICA Plaques
Variable
Symptomatic, %
(n21)*
Asymptomatic, %
(n32) P
Age (meanSD), y 687 715 NS
Male sex 56 59 NS
Hypertension 68 70 NS
Diabetes mellitus 16 16 NS
Smoking 84 76 NS
Hypercholesterolemia
(6.5 mmol/L)
64 62 NS
Stenosis 90% 24 22 NS
*One patient with an asymptomatic stenosis of the contralateral ICA is not
included.
Figure 5. Receiver operating characteristic curves for minimal
(min), mean, and maximal (max) FCT measurements. Area under
curve measures discrimination, that is, ability to correctly clas-
sify symptomatic from asymptomatic plaques. Area of 1 repre-
sents perfect test; area of 0.5 represents worthless test. Best
discrimination is achieved by measuring mean FCT and worst
(but still fair) by measuring minimal FCT.
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made with relatively little success.16 A recent interesting
study comparing carotid endarterectomy specimens with
preoperative carotid ultrasound results found that the best
factors for characterization of carotid plaques were thinning
and rupture of the FC17; however, that study treated FCT as
a dichotomous variable (thin: 1 mm, thick: 1 mm), did
not focus on FCT measurement, and was performed with an
ultrasound probe of 7.5 MHz.
The method of FTC measurement used in the present study
has certain limitations. First, there is a contrast-resolution
limitation in B-mode; even though modern ultrasound instru-
ments have an axial resolution that ranges from 200 to 600
m, in a few cases, it is impossible to measure the FC, which
is too thin. Similar difficulties are present for calcified or very
fibrotic plaques, particularly in cases with complete acoustic
shadowing. Second, there is a geometric-resolution limita-
tion; at the moment, we measure structures with a size very
close to or even smaller than the maximal resolution of the
ultrasound instrumentation that we are using. We therefore
run the risk that the FC will be melted together with the
background or with other close structures. Ultrasound also
has a tendency to shift toward the weaker echo side,18 which,
in the present case, would lead to an artificial enlargement of
the FCT because the cap was surrounded by weaker echoes
on either side of it (blood in the arterial lumen, and the lipid
core). Thus, the FCT value that we measured may be an
overestimation of the actual FCT; however, as shown by our
validation study, agreement between ultrasound and histology
was excellent for maximal and mean FCT, which confirms
that the distance measured between the hypoechogenic-
hyperechogenic and hyperechogenic-hypoechogenic inter-
face actually corresponds to the FC.
Third, there are problems posed by acoustic anisotropy: the
appearance of features will change depending on the angle of
insonation, and tissue interfaces may not be well seen unless
the ultrasound beam is perpendicular to the interface. Because
we measured FCT on a single frame at the region of maximal
lumen narrowing, we obtained far better visualization of the
central part of the plaque than of its shoulder regions in
80% of our cases. One could state that plaques having caps
that are thick over much of the necrotic core yet thinned (and
perhaps prone to rupture) over the shoulder regions may have
been misclassified as stable because of inadequate visualiza-
tion of the distal and trailing ends of the plaque; however, in
contrast to the coronaries, carotid plaque rupture appears to
occur mostly at the midportion of the plaque rather than at the
shoulder area.7 Moreover, luminal surface changes have been
shown to occur in the most severely stenotic regions of both
symptomatic and asymptomatic carotid plaques, with surface
irregularities being notably absent in areas of the plaque
distant from the stenosis.19 A 3D ultrasound technique would
probably allow a thorough assessment of the cap. However,
3D ultrasound is not widely available; different techniques
and transducers are still under development; it has a clearly
inferior axial resolution compared with 2D ultrasound, which
is crucial for FCT assessment; it cannot overcome acoustic
shadowing and artifacts present in 2D images; and it is further
limited by swallowing and respiration artifacts.20 Our purpose
was to develop an imaging method applicable to everyday
practice and not another research tool with limited clinical
applicability.
Fourth, the hypoechogenic structure just beneath the FC
was presumed to be the lipid core of the plaque. The only
other case in which a structure just beneath the plaque could
appear hypoechogenic would be that of an intraplaque hem-
orrhage; however, what we are interested in is FC thinning,
regardless of whether this is due to lipids or blood beneath the
FC. Therefore, even if an intraplaque hemorrhage is misdi-
agnosed as a lipid pool, this does not preclude measurement
of the FC as long as the cap is surrounded by hypoechogenic
structures that permit accurate detection of its boundaries. In
our histological study, we did not identify any cases of
important intraplaque hemorrhage. The real problem lies in
cases in which a carotid atheroma is highly calcified or
fibrous, in which a hypoechogenic structure beneath the FC
cannot be identified and therefore FC measurement is not
possible. For these reasons, FC measurement was not possi-
ble in 1 (5%) of 22 plaques of the validation study and in 4
(6.5%) of 62 plaques of the second data set. At present, we
cannot determine whether this percentage would be smaller
or bigger in a larger or different series of patients.
Fifth, adherent thrombi in the ICA constitute a rare entity
in patients with stroke and may have a different appearance
on high-resolution B-mode imaging (ranging from hypoecho-
genic to hyperechogenic) depending on their consistency and
age.21 During ultrasound FCT measurements, we did not
identify any patients with thrombi in our 2 data sets, and this
was confirmed by histology in the validation set; however,
ultrasound cannot exclude the presence of microaggregates of
platelets and thrombin on the plaque surface, because these
are well beyond the resolution of any existing ultrasound
instrument. It is highly unlikely that these microaggregates,
even if present, could have influenced the measurements.
TABLE 3. Suggested Cutoff FTC Values for Detection of Symptomatic ICA Plaques
Minimal FTC Mean FTC Maximal FTC
Decision threshold (95% CI),* mm; bootstrap SE 0.458 (0.446–0.471); 0.007 0.647 (0.639–0.654); 0.004 0.924 (0.912–0.935); 0.006
Sensitivity (95% CI),* %; bootstrap SE 72.7 (68.4–77.0); 2.21 81.8 (78.2–85.4); 1.84 77.3 (72.2–82.4); 2.6
Specificity (95% CI),* %; bootstrap SE 63.9 (59.4–68.4); 2.28 83.3 (79.4–87.3); 2.03 72.2 (69.8–74.7); 1.24
Positive predictive value, % 55.2 75 64.3
Negative predictive value, % 79.3 88.2 86.7
Correct classification rate, % 67.2 82.8 75.9
*Bootstrap CIs (1000 iterations).
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Sixth, FCT values obtained by histology were on average
slightly lower than those obtained by ultrasound, ranging
from 1.0% for maximal FCT to 3.4% for minimal FCT (Table
1). Tissue shrinkage during histological processing may
account for this small discrepancy. Two studies comparing
ultrasound and histology for intima-media thickness measure-
ments in the common carotid artery reported average differ-
ences of 4%22 and 14.6%.23 In the former study, tissue
shrinkage was only 2.5%. Our results are concordant with
these studies. Although we did not account for tissue shrink-
age, the agreement between ultrasound and histology was
very good, which suggests that shrinkage was probably
minimal. If considerable tissue shrinkage had occurred, a
very good agreement between ultrasound and histology
would have been possible only if ultrasound had systemati-
cally underestimated the actual FCT; however, as mentioned
above, ultrasound tends to overestimate rather than underes-
timate FCT.
Hitherto, a semiautomated ultrasound system to quantify
FCT and to investigate the clinical implications of this
parameter in symptomatic and asymptomatic ICA atheromata
has not been used. Our results are promising in terms of
application to stroke prevention; however, additional studies
to determine intrasonographer and intersonographer repro-
ducibility are needed before the current technique can be used
in clinical trials or in clinical practice. An ICA plaque with an
FC thinner than 0.65 mm may help the clinician to identify
patients with a higher risk of stroke. Nevertheless, only
prospective population-based studies will determine the value
of FCT, as evaluated by our method, for predicting the risk of
subsequent brain ischemia.
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